Fatty Liver Disease in Nordic Countries

Fatty Liver Disease in Nordic Countries (FLINC): a Prospective Cohort Study

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04340817

Acronym

FLINC

Enrollment

634

Registered

2020-04-10

Start date

2017-09-01

Completion date

2026-11-01

Last updated

2020-04-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-Alcoholic Fatty Liver Disease

Brief summary

A prospective cohort study, which aims to systematically evaluate biomarkers and potential targets in NAFLD and NASH.

Interventions

DIAGNOSTIC_TESTProteomics

Mass-spectometry proteomics

DIAGNOSTIC_TESTTranscriptomics

Next generation sequencing

GENETICGenomics

Targeted genetics

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

* Non-alcoholic fatty liver disease and * Healthy volunteers

Exclusion criteria

* Other liver diseases than non-alcoholic fatty liver disease * Lack of informed consent

Design outcomes

Primary

Measure	Time frame	Description
Fibrosis	5 years	Number of participants with fibrosis proression

Countries

Denmark

Contacts

Primary ContactLise L Gluud, MD

lise.lotte.gluud.01@regionh.dk+45 38623862

Backup ContactMikkel P Werge, MD

Mikkel.parsberg.werge@regionh.dk+45 38623862

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026